Amidi

Applications p-Hydroxymandelamide is a useful synthetic intermediate in the synthesis of Hydroxyatenolol (H802480); a metabolite of Atenolol (A790075) which is a cardioselective β-adrenergic blocker, antihypertensive, antianginal, and antiarrhythmic (class II).
References Escher, B., et al.: Environ. Sci. Technol., 40, 7402 (2006); Caplar, V., et al.: Anal. Profiles Drug Subs., 13, 1 (1984)

N-(2-Chlorophenyl)benzamide is a phenanthridone that reacts with chlorides in the presence of anilines to form singlet carbonyls. The photocyclization of these carbonyls yields an electron-deficient product that can be converted to a reactive electrophile by the addition of chlorine. This electrophilic species reacts with electron-rich aromatic compounds, such as phenols and benzene, to produce substitution products. The reaction rate for this process is dependent on the isotope effect, which is the change in reactivity due to changes in the mass number of atoms. The use of deuterium chloride instead of hydrogen chloride provides a kinetic isotope effect, which enhances the reaction rate.

Thiophene-2-carboxamide is a synthetic chemical that is an inhibitor of the efflux pump, receptor activity, and recombinant cytochrome p450. It has been shown to be effective against colorectal carcinoma cells in vitro and in vivo. Thiophene-2-carboxamide also inhibits the mitochondrial membrane potential and hydrogen bond formation. This compound has potent inhibitory activity for the enzyme synthetase, which may be a potential drug target for cancer treatment. Nitrogen atoms are present in this molecule.

1-Z-N'-Hydroxypropanimidamide is a novel anion that has been shown to inhibit the proliferation of human cancer cells. It binds to the cholinergic receptor subtype and inhibits the uptake of acetylcholine, which leads to a reduction in the production of nitric oxide. 1-Z-N'-Hydoxypropanimidamide also inhibits the growth of Mycobacterium tuberculosis and possesses antimycobacterial activity. This compound is a ligand that binds bidentate to both DNA and RNA molecules and inhibits chemokine signaling.

Sulfamide is a pharmacological agent that inhibits the growth of bacteria. Sulfamide has been shown to be reactive with hydrogen fluoride, which may result in the formation of sulfamoyl chloride. This reactive form of sulfamide may react with other compounds and cause unwanted side-effects.
Sulfamides are used for the treatment of infectious diseases such as pneumonia and urinary tract infections, as well as for the treatment of other conditions like congestive heart failure and rheumatoid arthritis. They work by inhibiting enzymes necessary for bacterial growth, including target enzymes such as dihydropteroate synthase, which is involved in folate synthesis. Sulfamides also have inhibitory properties on human osteosarcoma cell proliferation.

2-Iodo-N-methyl-N-p-tolylbenzamide is a fine chemical that has the CAS No. 1387529-49-8 and is a versatile building block with a wide range of applications, including research chemicals, reaction components and speciality chemicals. 2-Iodo-N-methyl-N-p-tolylbenzamide is soluble in organic solvents such as ethers, chloroform and benzene, while insoluble in water. It has been shown to be a useful intermediate for the synthesis of complex compounds and can be used as a reagent to prepare other compounds. 2Iodo-Nmethyl--Np--tolylbenzamide has been shown to have high quality and is an excellent building block for synthesizing pharmaceuticals.

1-Methyl-nicotinamide iodide is a drug that has been used in clinical trials for the treatment of type 2 diabetes mellitus. It is thought to work by increasing the sensitivity of cells to insulin, which may be related to its ability to bind to protein amide groups and form hydrogen bonds with the amino acid side chains. The compound also has been shown to increase the activity of the enzyme glycogen synthase in rats. 1-Methyl-nicotinamide iodide is soluble in water and human serum, and shows low solubility in ethanol. It has not been studied in humans, but animal studies have shown that it can be absorbed orally and metabolized into hippuric acid, which is excreted as a metabolic product through urine. Animal studies also showed that 1-methyl-nicotinamide iodide inhibits glucose production by pancreatic beta cells, which may lead to an increased insulin response after eating.